| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9956491 | International Journal of Cardiology | 2005 | 7 Pages |
Abstract
Serum MMP-2 varied in a time-dependent manner following AMI and correlated with late changes in LVEDVI. Serum MMP-2 levels were significantly lower in treatment group than in non-treatment group and ÎLVEDVI was significantly smaller in treatment group after long-term pravastatin administration. Use of statins in AMI patients may provide beneficial effects in terms of preventing heart failure over and above its lipid-lowering effects.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Reiko Nakaya, Hiroyasu Uzui, Hiromasa Shimizu, Akira Nakano, Yasuhiko Mitsuke, Taketoshi Yamazaki, Takanori Ueda, Jong-Dae Lee,